News Novel cancer immunotherapy research lands Innovate UK fundin... New programme will leverage well-validated genetic mechanisms to promote cancer immunity.
News Novartis app could revolutionise ophthalmic clinical trials Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis.
News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
News Novartis and Pear to develop substance use digital therapeut... Novartis is set to develop and commercialise a range of digital therapeutics for patients with substance and opioid use disorders as it expands its work with Pear Therapeutics through a dea
News UK biotech 'unicorn' BenevolentAI raises cash for further ex... R&D firm recently invested in Cambridge R&D base
News CHMP backs Novo's haemophilia A drug Frehemgo Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
